UCB Ventures
Overview
UCB Ventures is a €150 million strategic corporate venture fund established in 2017 by UCB, a global biopharmaceutical company focused on neurology and immunology disorders. The fund invests in early-stage companies in the US and Europe, focusing on novel therapeutic modalities, platforms and assets that address novel biology .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SonoThera | Jun 2026 | Series B | Co-investor |
| SpliceBio | Jun 2025 | Series B | - |
| Neurona Therapeutics | Apr 2025 | VC Round | - |
| Rinri Therapeutics | Jan 2025 | Series A | Co-investor |
| Neurona Therapeutics | Feb 2024 | Series E | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
